Stiff skin syndrome

What it is

From: Orphanet

Stiff skin syndrome is a rare, slowly progressive cutaneous disease characterized by rock-hard skin bound firmly to the underlying tissues (mainly on the shoulders, lower back, buttocks and thighs), mild hypertrichosis and hyperpigmentation overlying the affected areas of skin, as well as limited joint mobility (mainly of large joints) with flexion contractures. Cutaneous nodules, affecting mostly distal interphalangeal joints, as well as extracutaneous manifestations, including diffuse entrapment neuropathy, scoliosis, a tiptoe gait and a narrow thorax, may be associated. Restrictive pulmonary changes, muscle weakness, short stature and growth delay have also been reported. No vascular hyperreactivity, immunologic abnormalities nor visceral, muscular or bone involvement has been described.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Limitation of joint mobility · Very frequent (99-80%)

A reduction in the freedom of movement of one or more joints.

Thickened skin · Very frequent (99-80%)

Laminar thickening of skin.

Lack of skin elasticity · Very frequent (99-80%)

Hyperpigmentation of the skin · Frequent (79-30%)

A darkening of the skin related to an increase in melanin production and deposition.

Hypertrichosis · Frequent (79-30%)

Hypertrichosis is increased hair growth that is abnormal in quantity or location.

Abnormal circulating lipid concentration · Occasional (29-5%)

Any deviation from the normal concentration of lipid in the blood circulation.

Abnormality of the musculature · Occasional (29-5%)

Abnormality originating in one or more muscles, i.e., of the set of muscles of body.

Decreased body weight · Occasional (29-5%)

Abnormally low body weight.

Glaucoma · Occasional (29-5%)

Glaucoma refers loss of retinal ganglion cells in a characteristic pattern of optic neuropathy usually associated with increased intraocular pressure.

Hypertension · Occasional (29-5%)

The presence of chronic increased pressure in the systemic arterial system.

Impaired pain sensation · Occasional (29-5%)

Reduced ability to perceive painful stimuli.

Lipoatrophy · Occasional (29-5%)

Localized loss of fat tissue.

Midface retrusion · Occasional (29-5%)

Posterior positions and/or vertical shortening of the infraorbital and perialar regions, or increased concavity of the face and/or reduced nasolabial angle.

Muscle weakness · Occasional (29-5%)

Reduced strength of muscles.

Other findings in the same source

From: Orphanet

Additional reported features include Nephrolithiasis (Occasional (29-5%)); Peripheral neuropathy (Occasional (29-5%)); Retinal detachment (Occasional (29-5%)); Sensorineural hearing impairment (Occasional (29-5%)); Short stature (Occasional (29-5%)); Strabismus (Occasional (29-5%)); Subcutaneous nodule (Occasional (29-5%)); Type II diabetes mellitus (Occasional (29-5%)); Aplasia/Hypoplasia of the skin (Occasional (29-5%)); Autoimmune antibody positivity (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Childhood; Infancy; Neonatal

Inheritance in the source

From: Orphanet

Autosomal dominant

Frequency and the population described

From: Orphanet

Reported case(s): 54.0; Worldwide. This is a published case count, not prevalence. Point prevalence: <1 / 1 000 000; Worldwide; Class only.

Understanding the inheritance label

From: MedlinePlus Genetics

An autosomal dominant pattern means that one altered copy of a relevant gene can be sufficient for the condition. Some affected people inherit the change; others have a new change without an affected parent. The precise finding, family history and condition determine what this means for relatives.

Which doctor should you see?

The suggested department for discussing Stiff skin syndrome is Dermatology, with a dermatologist as the relevant type of clinician. Dermatologist; paediatric services for children as appropriate.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Which features of the skin, hair or nails distinguish the possibilities?
• Would photographs over time help document the changes?
• What should be expected from treatment, and how will irritation or other adverse effects be managed?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Stiff skin syndrome. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.